Sequenom and Gemini Genomics agree to merge in a $238m (£172.6m) stock-for-stock exchange

Sequenom advised by Lovells (John Davidson) and Cooley Godward. Gemini advised by Skadden Arps Slate Meagher & Flom (Martha McGarry, Michael Hatchard).